Latigo Biotherapeutics, Inc. LTGO
13.06 USD -0.18 (-1.36%)
As ofNov 20, 2026, 3:30 PM EST
11.91 Day range 13.35
10.24 52-week range 25.93
- YTD
- -28.44%
- 1 year
- -28.44%
Held by funds
19 US ETFs and mutual funds hold LTGO · largest positions
- FCNTX 0.01% of fund $14.50M
- VTI 0.00% of fund $10.51M
- FBIOX 0.15% of fund $8.80M
- VXF 0.00% of fund $3.60M
- FSPHX 0.05% of fund $3.55M
- FBTTX 0.14% of fund $3.20M
- FHCIX 0.05% of fund $1.76M
- FSCRX 0.07% of fund $1.53M
- FSMAX 0.00% of fund $1.48M
- SCHA 0.01% of fund $1.25M
- FNITX 0.00% of fund $821.64K
- FNCMX 0.00% of fund $372.94K
- VBINX 0.00% of fund $190.31K
- VITPX 0.00% of fund $169.37K
- SCHB 0.00% of fund $151.17K
- VTWO 0.00% of fund $132.18K
- VTWG 0.00% of fund $13.19K
- VTWV 0.00% of fund $4.74K
- VTHR 0.00% of fund $1.99K
Ownership
- Institutions 80.7%
- Insiders 4.98%
- Public and other holders 14.3%
Held by insiders 4.98%
Held by institutions 80.73%
Float held by institutions 84.95%
Institutions 12
Top institutional holders
No holders on record
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Contrafund | 1.42% | 940,228 | 14.61M | Aug 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.72% | 480,316 | 7.46M | Aug 30, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 0.32% | 212,500 | 3.30M | Aug 30, 2026 |
| Fidelity Contrafund-Fidelity Contrafund K6 | 0.30% | 199,400 | 3.10M | Aug 30, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 0.29% | 191,400 | 2.97M | Aug 30, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 0.16% | 105,200 | 1.63M | Aug 30, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 5AM VENTURES VI, L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 9, 2026 | 0 |
| FORESITE CAPITAL MANAGEMENT V, LLC. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 9, 2026 | 0 |
| SANOFI SA | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 9, 2026 | 0 |
| SEIDENBERG BETH C | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 9, 2026 | 0 |
| TANANBAUM JAMES B | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 9, 2026 | 0 |
| WESTLAKE BIOPARTNERS FUND I, L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 9, 2026 | 0 |
